When patients look to you for answers, look to us for insights.
Solving today’s most complex health challenges starts with putting the right data insights in the hands of the right people. At Memorial Sloan Kettering Cancer Center (MSK), we are leading the field of specialty oncology data and insights.
MSK-CHORD combines de-identified longitudinal clinical information and genomic
data from MSK’s comprehensive genomic profiling tests for both solid tumors and
hematologic malignancies. Data covers all prevalent cancer types, as well as rare cancers. Clinically relevant and actionable biomarkers are represented among the datasets.
Licensing Opportunities
For more information, please contact MSK’s Digital Health - Business Development & Licensing team at [email protected] .
Stage of Development
Ready to use
Indications